{"DataElement":{"publicId":"2220310","version":"1","preferredName":"Venous Thrombosis Prior Anticoagulant Specify","preferredDefinition":"the free text field to specify the anticoagulant the patient received prior to the VTE.","longName":"V_THRM_PR_ACOAG_SPEC","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2220307","version":"1","preferredName":"Venous Thrombosis Prior Anticoagulant","preferredDefinition":"information relating to venous thrombosis prior anticoagulant.","longName":"VEN_THRMB_PR_ANTCOAG","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2220298","version":"1","preferredName":"Venous Thrombosis","preferredDefinition":"Of, or pertaining to, or contained in, or performing the function of the veins.:(throm-BOW-sis) The formation or presence of a blood clot inside a blood vessel.","longName":"C25291:C26891","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Venous","conceptCode":"C25291","definition":"Of, or pertaining to, or contained in, or performing the function of the veins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Thrombosis","conceptCode":"C26891","definition":"The formation of a blood clot in the lumen of a vessel or heart chamber; causes include coagulation disorders and vascular endothelial injury.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F428C665-7A82-2F56-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-12","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-04-12","modifiedBy":"ONEDATA","dateModified":"2005-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2220305","version":"1","preferredName":"Prior Anticoagulant Agent","preferredDefinition":"Earlier in time or order.:Agents that prevent blood clotting. Naturally occurring agents in the blood are included only when they are used as drugs.","longName":"C25629:C263","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Anticoagulant Agent","conceptCode":"C263","definition":"Any agent capable of preventing blood clot formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F428C665-7A9B-2F56-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-12","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-04-12","modifiedBy":"ONEDATA","dateModified":"2005-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F428C665-7A9D-2F56-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-12","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-04-12","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018810","version":"1","preferredName":"Therapies Specify","preferredDefinition":"the free text field related to therapy.","longName":"TX_SPEC","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184338","version":"1","preferredName":"Specify","preferredDefinition":"Specify; be specific about something; define clearly.","longName":"Specify","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-2084-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9BA236E-6B3E-350B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-03-25","modifiedBy":"CAMPBELB","dateModified":"2008-03-28","changeDescription":"released as entered during ISO compliance update","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Yes, specify","type":"Preferred Question Text","description":"Yes, specify","url":null,"context":"CTEP"}],"origin":"CALGB CRF:Cancer and Leukemia Group B Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F48EE588-D0AF-6842-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-12","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-04-12","modifiedBy":"CAMPBELB","dateModified":"2011-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}